Today, we look at a contrarian insider situation. When Nutrien Ltd. NTR-T released third-quarter results on Nov. 2, it lowered 2022 full-year guidance. The agriculture chemicals maker and distributor expects 2022 adjusted net earnings of midpoint US$13.875 per share, versus midpoint US$16.80 previously. As investors sold, insiders bought. From Nov. 4-9, three insiders bought a total of 8,980 common shares at an average price of $101.83. The most recent insider purchase was from President, Director, and CEO Ken Seitz, who bought 7,790 shares at $102.18.
Ted Dixon is CEO of INK Research which provides insider news and knowledge to investors. For more background on insider reporting in Canada, visit the FAQ section at www.inkresearch.com. Securities referenced in this profile may have already appeared in recent reports distributed to INK subscribers. INK staff may also hold a position in profiled securities.
Chart reflects public-market transactions of common shares or unit trusts by company officers and directors.
Be smart with your money. Get the latest investing insights delivered right to your inbox three times a week, with the Globe Investor newsletter. Sign up today.